Metsera (MTSR) shares rose sharply in their trading debut on Nasdag Friday after the company priced its initial public offering of almost 15.3 million shares at $18 per share.
The stock was up about 45% at $26.10 in recent trading after opening at $25.50.
The clinical-stage biotechnology company granted its underwriters a 30-day option to buy up to roughly 2.3 million additional shares. It expects to close the offering Monday.
BofA Securities, Goldman Sachs, Evercore ISI, Guggenheim Securities and Cantor are joint bookrunners for the offering.
Price: 26.31, Change: +8.31, Percent Change: +46.17
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.